| Lonza Group AG | 657.20 / -0.30% |
| Date/Time | 06/18 / 14:51 |
| Chg. / Chg.(%) | -2.00 / -0.30% |
| Bid | 657.00 / 97 |
| Ask | 657.40 / 78 |
| Open | 657.80 |
| Previous Close | 659.20 |
| High | 661.80 |
| Low | 655.60 |
| Volume [CHF] | 9,697,537.50 |
| Volume [Units] | 14,713 |
| Price fixings | 1324 |
| ISIN | CH0013841017 |
| Security | LONN/Z |
| Exchange | Cboe Europe CXE |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| SIX Swiss Ex.. | 657.40 |  |
328,999 |
| Cboe Europe .. | 657.60 | |
15,326 |
| Cboe Europe .. | 657.20 | |
14,713 |
| London Inter.. | 657.40 | |
13,303 |
| Turquoise | 657.40 | |
7,240 |
| Lang & Schwa.. | 596.600 | |
|
| Nasdaq Other.. | 713.2400 |  |
787 |
| Mexico | 14,126.90 |  |
7,060 |
| TradeGate | 294.000 | 298 | |
| Frankfurt | 293.9000 | 63 | |
| Düsseldorf | 291.20 | 0 | |
| München | 291.30 | 0 | |
| Berlin | 296.90 | 0 | |
| Hamburg | 291.30 | 0 | |
| gettex | 296.100 | ||
| Singapore | 79.97 | 500 | |
| EUREX | Options | ||
News
- aTyr Pharma and Lonza Announce Manufacturing Agreement for aTyr’s Anti-NRP2 Antibody ATYR2810
04/14/2021 / 14:00 - GlobeNewswire - Altimmune Expands AdCOVID™ Manufacturing Collaboration with Lonza
03/12/2021 / 07:00 - GlobeNewswire - Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy and Other Indications
01/12/2021 / 15:05 - GlobeNewswire - Achilles Therapeutics Appoints Arjan Roozen as VP, Site Head and General Manager
01/08/2021 / 13:00 - GlobeNewswire - Arbor Biotechnologies and Lonza Enter into Gene Editing Technology Licensing Deal
12/23/2020 / 14:00 - GlobeNewswire
Real-time